TYRA tyra.bio Net earnings per share growth forecast for next year

Corporate company logo of Tyra Corp (TYRA)

Tyra Biosciences, Inc. (TYRA) develops targeted oncology drugs via its SNAP IT platform, aiming for high margins through serial production. The forward EPS forecast for the coming year reflects evolving expectations, where the -7.20 indicator expresses the state of the metric. Tyra Biosciences, Inc. (TYRA) attracts leading scientists through flexible management while remaining at the pre-commercial stage, with capital fully allocated to long-term research and development.

TYRA: Tyra Biosciences Inc Net earnings per one share growth forecast for next year 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for Tyra Biosciences (TYRA)

- share price and consensus valuation forecast:
Fundamental company analysis:Tyra Biosciences, TYRA
Brand item of tyra.bio

For investors assessing the financial stability of an asset, this indicator serves as a measure of the expected growth rate of earnings per share, calculated as the arithmetic mean of analysts' forecasts for the coming period. The trend in projected earnings per share for the next year reflects the monetization potential of the Tyra Biosciences, Inc. (TYRA) platform for creating targeted FGFR inhibitors to combat tumor resistance.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|KYMR (Kymera) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences Inc)|Net earnings per one share growth forecast for next year Enliven Pharma|ORIC Pharmaceuticals Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Expected earnings per share growth for next year|VSTM: Projected earnings per share increase next year|GLUE (monterosatx.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Cullinan Therapeutics Inc CGEM|Earnings growth forecast for next year IMRX|C4 Therapeutics - Projected earnings per share growth rate for next year|Black Diamond Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year RPTX|PMVP: Expected earnings per share growth for next year|karyopharm.com - Projected earnings per share increase next year|PPCB: Earnings growth forecast for next year|Bio Green Med Solution Inc - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year aileronrx.com ALRN|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)